Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Molly Pugh-Jones"'
Autor:
Maia Salholz-Hillel, Molly Pugh-Jones, Nicole Hildebrand, Tjada A. Schult, Johannes Schwietering, Peter Grabitz, Benjamin Gregory Carlisle, Ben Goldacre, Daniel Strech, Nicholas J. DeVito
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-14 (2023)
Abstract Background The results of clinical trials should be completely and rapidly reported during public health emergencies such as COVID-19. This study aimed to examine when, and where, the results of COVID-19 clinical trials were disseminated thr
Externí odkaz:
https://doaj.org/article/d93723fe12c247bf96a9102040eb613e
Publikováno v:
BMJ Open, Vol 11, Iss 11 (2021)
Externí odkaz:
https://doaj.org/article/03364a196c774cf3972184ba9bbd4cdc
Autor:
Toby Pepperrell, Florence Rodgers, Pranav Tandon, Kelly Sarsfield, Molly Pugh-Jones, Theo Rashid, Sarai Keestra
Publikováno v:
Global Health Action, Vol 14, Iss 1 (2021)
Coronavirus disease 2019 (COVID-19) mortality and morbidity have been shown to increase with deprivation and impact non-White ethnicities more severely. Despite the extra risk Black, Asian and Minority Ethnicity (BAME) groups face in the pandemic, ou
Externí odkaz:
https://doaj.org/article/31636d1c3dc5443c82ea586eb444e061
ObjectiveTo examine how and when the results of COVID-19 clinical trials are disseminated.DesignCross-sectional bibliographic studySettingThe COVID-19 clinical trial landscapeParticipants285 registered interventional clinical trials for the treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d1e51dc72f92ad28d52c6fa7d98c7f7
https://doi.org/10.1101/2021.04.07.21255071
https://doi.org/10.1101/2021.04.07.21255071